Viewing Study NCT00598169


Ignite Creation Date: 2025-12-24 @ 10:53 PM
Ignite Modification Date: 2025-12-30 @ 8:37 AM
Study NCT ID: NCT00598169
Status: COMPLETED
Last Update Posted: 2020-08-10
First Post: 2008-01-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma
Sponsor: AIDS Malignancy Consortium
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module